These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27837167)

  • 21. Nrf2 activation is required for curcumin to induce lipocyte phenotype in hepatic stellate cells.
    Lu C; Xu W; Zheng S
    Biomed Pharmacother; 2017 Nov; 95():1-10. PubMed ID: 28826090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells.
    Lee S; Hallis SP; Jung KA; Ryu D; Kwak MK
    Redox Biol; 2019 Jun; 24():101210. PubMed ID: 31078780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces hepatic steatosis and endoplasmic reticulum stress by inducing nuclear factor erythroid-derived 2-related factor 2 nuclear translocation.
    Yoo J; Cho IJ; Jeong IK; Ahn KJ; Chung HY; Hwang YC
    Toxicol Appl Pharmacol; 2018 Dec; 360():18-29. PubMed ID: 30253173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relevance of FXR-p62/SQSTM1 pathway for survival and protection of mouse hepatocytes and liver, especially with steatosis.
    Haga S; Yimin ; Ozaki M
    BMC Gastroenterol; 2017 Jan; 17(1):9. PubMed ID: 28086800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIF-1α and HIF-2α are critically involved in hypoxia-induced lipid accumulation in hepatocytes through reducing PGC-1α-mediated fatty acid β-oxidation.
    Liu Y; Ma Z; Zhao C; Wang Y; Wu G; Xiao J; McClain CJ; Li X; Feng W
    Toxicol Lett; 2014 Apr; 226(2):117-23. PubMed ID: 24503013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-8 exacerbates alcohol-induced fatty liver disease via the Akt/HIF-1α pathway in human IL-8-expressing mice.
    Wang Z; Li B; Jiang H; Ma Y; Bao Y; Zhu X; Xia H; Jin Y
    Cytokine; 2021 Feb; 138():155402. PubMed ID: 33352397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential transcriptional regulation of hypoxia-inducible factor-1α by arsenite under normoxia and hypoxia: involvement of Nrf2.
    Al Taleb Z; Petry A; Chi TF; Mennerich D; Görlach A; Dimova EY; Kietzmann T
    J Mol Med (Berl); 2016 Oct; 94(10):1153-1166. PubMed ID: 27286880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction.
    Shao T; Zhao C; Li F; Gu Z; Liu L; Zhang L; Wang Y; He L; Liu Y; Liu Q; Chen Y; Donde H; Wang R; Jala VR; Barve S; Chen SY; Zhang X; Chen Y; McClain CJ; Feng W
    J Hepatol; 2018 Oct; 69(4):886-895. PubMed ID: 29803899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts.
    Trebicka J; Racz I; Siegmund SV; Cara E; Granzow M; Schierwagen R; Klein S; Wojtalla A; Hennenberg M; Huss S; Fischer HP; Heller J; Zimmer A; Sauerbruch T
    Liver Int; 2011 Jul; 31(6):860-70. PubMed ID: 21645218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effect of oligomeric proanthocyanidins against alcohol-induced liver steatosis and injury in mice.
    Wang Z; Su B; Fan S; Fei H; Zhao W
    Biochem Biophys Res Commun; 2015 Mar; 458(4):757-62. PubMed ID: 25680468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Digoxin improves steatohepatitis with differential involvement of liver cell subsets in mice through inhibition of PKM2 transactivation.
    Zhao P; Han SN; Arumugam S; Yousaf MN; Qin Y; Jiang JX; Torok NJ; Chen Y; Mankash MS; Liu J; Li J; Iwakiri Y; Ouyang X
    Am J Physiol Gastrointest Liver Physiol; 2019 Oct; 317(4):G387-G397. PubMed ID: 31411894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curcumin regulates endogenous and exogenous metabolism via Nrf2-FXR-LXR pathway in NAFLD mice.
    Yan C; Zhang Y; Zhang X; Aa J; Wang G; Xie Y
    Biomed Pharmacother; 2018 Sep; 105():274-281. PubMed ID: 29860219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIF-1-dependent lipin1 induction prevents excessive lipid accumulation in choline-deficient diet-induced fatty liver.
    Arai T; Tanaka M; Goda N
    Sci Rep; 2018 Sep; 8(1):14230. PubMed ID: 30242180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lycopene Prevents DEHP-Induced Liver Lipid Metabolism Disorder by Inhibiting the HIF-1α-Induced PPARα/PPARγ/FXR/LXR System.
    Zhao Y; Ma DX; Wang HG; Li MZ; Talukder M; Wang HR; Li JL
    J Agric Food Chem; 2020 Oct; 68(41):11468-11479. PubMed ID: 32962341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocyte-specific Keap1 deletion reduces liver steatosis but not inflammation during non-alcoholic steatohepatitis development.
    Ramadori P; Drescher H; Erschfeld S; Schumacher F; Berger C; Fragoulis A; Schenkel J; Kensler TW; Wruck CJ; Trautwein C; Kroy DC; Streetz KL
    Free Radic Biol Med; 2016 Feb; 91():114-26. PubMed ID: 26698665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blockade of hedgehog pathway is required for the protective effects of magnesium isoglycyrrhizinate against ethanol-induced hepatocyte steatosis and apoptosis.
    Lu C; Xu W; Shao J; Zhang F; Chen A; Zheng S
    IUBMB Life; 2017 Jul; 69(7):540-552. PubMed ID: 28500689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1α regulation in vitro and in vivo.
    Park MJ; Kim DI; Lim SK; Choi JH; Kim JC; Yoon KC; Lee JB; Lee JH; Han HJ; Choi IP; Kim HC; Park SH
    J Hepatol; 2014 Nov; 61(5):1151-7. PubMed ID: 25003952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver-specific Nrf2 deficiency accelerates ethanol-induced lethality and hepatic injury in vivo.
    Sun J; Hong Z; Shao S; Li L; Yang B; Hou Y; Wang H; Xu Y; Zhang Q; Pi J; Fu J
    Toxicol Appl Pharmacol; 2021 Sep; 426():115617. PubMed ID: 34116071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spleen tyrosine kinase regulates crosstalk of hypoxia-inducible factor-1α and nuclear factor (erythroid-derived2)-like 2 for B cell survival.
    Jang JW; Park S; Moon EY
    Int Immunopharmacol; 2021 Jun; 95():107509. PubMed ID: 33761438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxygen therapy alleviates hepatic steatosis by inhibiting hypoxia-inducible factor-2α.
    Yu L; Wang H; Han X; Liu H; Zhu D; Feng W; Wu J; Bi Y
    J Endocrinol; 2020 Jul; 246(1):57-67. PubMed ID: 32369776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.